0001209191-15-039579.txt : 20150506 0001209191-15-039579.hdr.sgml : 20150506 20150506183536 ACCESSION NUMBER: 0001209191-15-039579 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150505 FILED AS OF DATE: 20150506 DATE AS OF CHANGE: 20150506 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Auspex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001454189 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954862842 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3333 N. TORREY PINES COURT STREET 2: SUITE 400 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 558-2400 MAIL ADDRESS: STREET 1: 3333 N. TORREY PINES COURT STREET 2: SUITE 400 CITY: LA JOLLA STATE: CA ZIP: 92037 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GREER R SCOTT CENTRAL INDEX KEY: 0001211703 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36292 FILM NUMBER: 15838766 MAIL ADDRESS: STREET 1: 26 WHITE PINE CANYON RD CITY: PARK CITY STATE: UT ZIP: 84060 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-05-05 1 0001454189 Auspex Pharmaceuticals, Inc. ASPX 0001211703 GREER R SCOTT C/O AUSPEX PHARMACEUTICALS, INC. 3333 N. TORREY PINES CT., STE. 400 SAN DIEGO CA 92037 1 0 0 0 Common Stock 2015-05-05 4 U 0 7190 D 0 D Stock Option (Right to Buy) 18.13 2015-05-05 4 D 0 20000 D 2024-05-05 Common Stock 20000 0 D Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated March 29, 2015, among the Issuer, Teva Pharmaceuticals Industries Ltd. ("Parent"), and Aurum Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub") in exchange for a cash consideration of $101.00 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation (the "Merger"). This option, which is fully vested, was cancelled in the Merger in exchange for a cash payment equal to $101.00 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the stock option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. /s/ Robert Daniel, Attorney-in-fact 2015-05-05